Has Dana Demoss received payments from drug or device companies?

Yes. Drug and device makers reported $75,813 in general payments to Dana Demoss across 388 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dana Demoss did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dana Demoss come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dana Demoss

Women's Health · Nashville, TNNPI 1346241130

Payments from drug & device makers

$75,813in general payments, 2019–2025

Across 388 payments — averaging $195.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$62K
GSK$5K
Merck$2K
Johnson & Johnson$654
Regeneron Healthcare Solutions, Inc.$512
Novartis$470
plus $6K from 52 others

What the payments were for

Consulting fees$1,5332%
Speaking & faculty fees$50,03066%
Travel & lodging$12,32116%
Food & beverage$11,86316%
Education$670%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	108	$61,682
GSK	14	$4,758
Merck	21	$2,058
Johnson & Johnson(2 entities)	18	$654
Regeneron Healthcare Solutions, Inc.	16	$512
Novartis	17	$470
E.r. Squibb & Sons, L.L.C.	7	$436
Seagen Inc.	6	$392
Daiichi Sankyo Inc.	10	$361
Bristol Myers Squibb	13	$291
Myriad Genetic Laboratories, Inc.	3	$278
Bayer	11	$259
Jazz Pharmaceuticals Inc.	7	$241
AVEO Pharmaceuticals, Inc.	6	$234
Eisai Inc.	9	$228
Servier Pharmaceuticals LLC	5	$196
Sanofi	7	$193
Takeda Pharmaceuticals U.S.A., Inc.	6	$188
Gilead(2 entities)	4	$182
Tersera Therapeutics LLC	8	$151
AbbVie	7	$145
Immunogen, Inc.	2	$121
Incyte Corporation	5	$119
Puma Biotechnology, Inc.	6	$105
Astellas Pharma US Inc	4	$102
Pfizer	4	$96
Lilly USA, LLC	4	$94
EMD Serono, Inc.	4	$77
Exelixis Inc.	3	$74
Pharmaessentia USA Corporation	3	$70
Sun Pharmaceutical Industries Inc.	3	$70
Rigel Pharmaceuticals, Inc.	3	$67
Pharmacosmos Therapeutics Inc.	3	$60
Sobi, Inc	3	$57
Genentech USA, Inc.	3	$51
Iovance Biotherapeutics, Inc.	2	$51
Genmab U.S., Inc.	2	$50
Pharmacyclics LLC, An Abbvie Company	2	$45
Blueprint Medicines Corporation	1	$45
Boehringer Ingelheim	2	$43
Amgen	2	$41
G1 Therapeutics, Inc.	2	$40
Morphosys, US Inc.	2	$39
Mirati Therapeutics, Inc.	2	$39
Array Biopharma Inc	2	$38
ADC Therapeutics America, Inc.	2	$36
Stemline Therapeutics Inc.	2	$35
Sumitomo Pharma America, Inc.	2	$31
Taiho Oncology, Inc.	1	$27
Shield Therapeutics Inc	1	$22
Cycle Pharmaceuticals Inc	1	$22
Coherus Oncology, Inc.	1	$22
Geron Corporation	1	$21
Macrogenics, Inc.	1	$21
Karyopharm Therapeutics Inc.	1	$20
Beigene USA, Inc.	1	$19
CTI Biopharma Corp.	1	$19
Deciphera Pharmaceuticals Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LYNPARZA$59,667
ZEJULA$4,167
KEYTRUDA$1,455
Enhertu$250
OPDIVO$246
TIVDAK$226
TAGRISSO$125
RYBREVANT$124
BLENREP$124
XARELTO$124
JEMPERLI$121
ZIIHERA$117
myRisk$117
TUKYSA$115
myChoice CDx$100

How this compares

$75,813 in reported general payments places this provider in the 95th percentile of 202 women's health providers in Tennessee.

See all women's health providers in Tennessee →

Medicare billing

Part B allowed, 2024

$12,324

Medicare patients

Services billed

845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	29	$877
Alprazolam	12	$41
Fluconazole	15	$20

Paid to pharmacies, not to this prescriber.

Other women's health in Nashville

Royanne MooreNashville$29K
Lana HirschNashville$24K
Yoshie DarnallNashville$10K
Lisa GoehringNashville$9K
Lindsey BakshNashville$6K
Catherine WalkerNashville$5K
Jordan VaughanNashville$5K
Margaret HullNashville$5K
Rebecca MooneyNashville$4K
Ashley GreerNashville$3K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →